Tradeoffs in Introduction Policies for the Anti-Tuberculosis Drug Bedaquiline: A Model-Based Analysis.
New drugs for the treatment of tuberculosis (TB) are becoming available for the first time in over 40 y. Optimal strategies for introducing these drugs have not yet been established. The objective of this study was to compare different strategies for introducing the new TB drug bedaquiline based on...
Main Authors: | Amber Kunkel, Frank G Cobelens, Ted Cohen |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2016-10-01
|
Series: | PLoS Medicine |
Online Access: | http://europepmc.org/articles/PMC5058480?pdf=render |
Similar Items
-
EFFICIENCY OF CHEMOTHERAPY WITH BEDAQUILINE IN DRUG RESISTANT PULMONARY TUBERCULOSIS PATIENTS
by: A. M. Tikhonov, et al.
Published: (2018-03-01) -
Bedaquiline in the treatment of extensively drugresistant tuberculosis
by: T. I. Morozova, et al.
Published: (2022-04-01) -
Acquired resistance of Mycobacterium tuberculosis to bedaquiline.
by: Koen Andries, et al.
Published: (2014-01-01) -
Efficacy and safety of regimen containing bedaquiline in children with drug-resistant tuberculosis
by: V. A. Aksenova, et al.
Published: (2021-10-01) -
Primary Bedaquiline Resistance Among Cases of Drug-Resistant Tuberculosis in Taiwan
by: Sheng-Han Wu, et al.
Published: (2021-10-01)